Skip to main content
Premium Trial:

Request an Annual Quote

Mission Bio Tapestri, Panels

Mission Bio has updated its Tapestri single-cell DNA analysis platform, which is now compatible with the Illumina HiSeq 2500 sequencer to allow for multiplexing and larger panels.

The company has also launched two new panels for myeloid disorders and for solid tumor profiling. The Tapestri Single-Cell DNA Myeloid Panel, designed to cover several myeloid disorders, targets single-nucleotide variants and indels in 47 genes. The Tapestri Single-Cell Tumor Hotspot Panel targets SNV and indel hotspot mutations across 50 genes involved in different solid tumor types and has been tested with breast, lung, prostate, and colorectal cancer nuclei from fresh-frozen tissue samples.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.